tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PainChek schedules investor webinar to follow January quarterly update

Story Highlights
  • PainChek is a global medtech firm offering AI-based pain assessment apps with broad regulatory approvals.
  • The company will hold an investor webinar on 30 January 2026 after releasing its quarterly update and cash report.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
PainChek schedules investor webinar to follow January quarterly update

Claim 50% Off TipRanks Premium

PainChek Ltd ( (AU:PCK) ) has provided an update.

PainChek Ltd, a global medtech company specialising in AI-driven pain assessment tools delivered via smartphones and tablets, has established a strong presence in aged care and related sectors, with regulatory approvals in multiple major markets and adoption in thousands of facilities worldwide. The company has announced it will host an investor webinar on 30 January 2026, following the release of its quarterly update and cash flow report, giving shareholders and investors an opportunity to hear the latest presentation from the CEO and ask questions, signalling continued engagement with the market as it advances the rollout and commercialisation of its pain assessment technology across clinical and home care settings.

The most recent analyst rating on (AU:PCK) stock is a Hold with a A$0.26 price target. To see the full list of analyst forecasts on PainChek Ltd stock, see the AU:PCK Stock Forecast page.

More about PainChek Ltd

PainChek Ltd is an Australian medical technology company that has developed PainChek, the world’s first regulatory-cleared smart device-based medical device for pain assessment and monitoring. Its smartphone and tablet app uses AI to automate multidimensional pain assessments, integrates the Numerical Rating Scale, and provides analytics to support accurate and consistent pain management at the point of care. PainChek targets aged care, disability, and home care markets globally, with regulatory clearance across Australia, the USA, Canada, the EU, New Zealand, Singapore, Malaysia and the UK, and is deployed in more than 2,000 aged care facilities where over 17 million digital pain assessments have been conducted, particularly benefiting people with dementia, infants, and others unable to reliably self-report pain.

Average Trading Volume: 177,809

Technical Sentiment Signal: Sell

Current Market Cap: A$56.43M

Find detailed analytics on PCK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1